Literature DB >> 24122699

Application of a quality by design approach to the cell culture process of monoclonal antibody production, resulting in the establishment of a design space.

Hiroaki Nagashima1, Akiko Watari, Yasuharu Shinoda, Hiroshi Okamoto, Shinya Takuma.   

Abstract

This case study describes the application of Quality by Design elements to the process of culturing Chinese hamster ovary cells in the production of a monoclonal antibody. All steps in the cell culture process and all process parameters in each step were identified by using a cause-and-effect diagram. Prospective risk assessment using failure mode and effects analysis identified the following four potential critical process parameters in the production culture step: initial viable cell density, culture duration, pH, and temperature. These parameters and lot-to-lot variability in raw material were then evaluated by process characterization utilizing a design of experiments approach consisting of a face-centered central composite design integrated with a full factorial design. Process characterization was conducted using a scaled down model that had been qualified by comparison with large-scale production data. Multivariate regression analysis was used to establish statistical prediction models for performance indicators and quality attributes; with these, we constructed contour plots and conducted Monte Carlo simulation to clarify the design space. The statistical analyses, especially for raw materials, identified set point values, which were most robust with respect to the lot-to-lot variability of raw materials while keeping the product quality within the acceptance criteria.
© 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

Entities:  

Keywords:  antibody; biotechnology; cell culture; design of experiments; design space; failure mode and effects analysis; mathematical models; multivariate analysis; proteins; quality by design

Mesh:

Substances:

Year:  2013        PMID: 24122699     DOI: 10.1002/jps.23744

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Early integration of Design of Experiment (DOE) and multivariate statistics identifies feeding regimens suitable for CHO cell line development and screening.

Authors:  Alessandro Mora; Bernard Nabiswa; Yuanyuan Duan; Sheng Zhang; Gerald Carson; Seongkyu Yoon
Journal:  Cytotechnology       Date:  2019-11-09       Impact factor: 2.058

2.  Optimization of a mAb production process with regard to robustness and product quality using quality by design principles.

Authors:  Ole Jacob Wohlenberg; Carlotta Kortmann; Katharina V Meyer; Jana Schellenberg; Katharina Dahlmann; Janina Bahnemann; Thomas Scheper; Dörte Solle
Journal:  Eng Life Sci       Date:  2022-06-03       Impact factor: 3.405

3.  Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach.

Authors:  Jianqi Nie; Yang Sun; Fei Han; Yankun Yang; Xiuxia Liu; Chunli Liu; Ye Li; Zhonghu Bai
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

4.  Implementation of QbD strategies in the inoculum expansion of a mAb production process.

Authors:  Ole Jacob Böhl; Jana Schellenberg; Janina Bahnemann; Bernd Hitzmann; Thomas Scheper; Dörte Solle
Journal:  Eng Life Sci       Date:  2020-12-03       Impact factor: 2.678

Review 5.  Clever Experimental Designs: Shortcuts for Better iPSC Differentiation.

Authors:  Ryota Yasui; Keisuke Sekine; Hideki Taniguchi
Journal:  Cells       Date:  2021-12-15       Impact factor: 6.600

Review 6.  Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design.

Authors:  Araceli Rivera-Ordaz; Valeria Peli; Paolo Manzini; Mario Barilani; Lorenza Lazzari
Journal:  BioDrugs       Date:  2021-11-02       Impact factor: 5.807

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.